Free Access
Med Sci (Paris)
Volume 32, Number 3, Mars 2016
Page(s) 244 - 246
Section Nouvelles
Published online 23 March 2016
  1. Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 2012 ; 12 : 269–281. [CrossRef] [PubMed] [Google Scholar]
  2. Hoves S, Krause SW, Schütz C, et al. Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J Immunol 2006 ; 177 : 2691–2698. [CrossRef] [PubMed] [Google Scholar]
  3. Cann H, A S, Netten V, et al. Dr William Coley and tumour regression: a place in history or in the future. Postgrad Med J 2003 ; 79 : 672–680. [PubMed] [Google Scholar]
  4. Vingert B, Adotevi O, Patin D, et al. The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur J Immunol 2006 ; 36 : 1124–1135. [CrossRef] [PubMed] [Google Scholar]
  5. Müller U, Steinhoff U, Reis LF, et al. Functional role of type I and type II interferons in antiviral defense. Science 1994 ; 264 : 1918–1921. [CrossRef] [PubMed] [Google Scholar]
  6. Thoreau M, Penny HL, Tan K, et al. Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site. Oncotarget 2015 ; 6 : 27832–27846. [CrossRef] [PubMed] [Google Scholar]
  7. Zhu Y, Knolhoff BL, Meyer MA, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res 2014 ; 74 : 5057–5069. [CrossRef] [Google Scholar]
  8. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008 ; 8 : 533–544. [CrossRef] [PubMed] [Google Scholar]
  9. Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014 ; 41 : 49–61. [CrossRef] [PubMed] [Google Scholar]
  10. Dalton DK, Pitts-Meek S, Keshav S, et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993 ; 259 : 1739–1742. [CrossRef] [PubMed] [Google Scholar]
  11. Long KB, Beatty GL. Harnessing the antitumor potential of macrophages for cancer immunotherapy. Oncoimmunology 2013 ; 2 : e26860. [CrossRef] [PubMed] [Google Scholar]
  12. Tartour E, Sandoval F, Bonnefoy JY, Fridman WH. Immunothérapie des cancers. Med Sci (Paris) 2011 ; 27 : 833–841. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. Teillaud JL. Quand les anticorps rencontrent l’immunité antitumorale : fin de partie pour la cellule cancéreuse ? Med Sci (Paris) 2015 ; 31 : 707–708. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Treps L, Gavard J. L’angiogenèse tumorale : quand l’arbre de vie tourne mal. Med Sci (Paris) 2015 ; 31 : 989–995. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.